Dr. Panos Ntziachristos is a molecular and cancer biologist trained in University of Athens, Greece, and New York University, US. He is a Professor at the Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University, Belgium. His research focuses on uncovering how post-transcriptional and epigenetic mechanisms influence leukemia progression and drug resistance. Key areas of investigation include how large biochemical complexes such as RNA biology players are regulated, how their dysregulation occurs, and how this affects cancer progression.
Dr. Ntziachristos has authored several high-impact peer-reviewed publications in journals including Nature, Nature Medicine and Cancer Discovery. He serves in intramural committees at Ghent University and has guided the careers of several early-career scientists. He also serves on the Research Committee of the European Hematology Association (EHA) and is a coorganizer of major scientific events, e.g. the 2025 Research Conference of the EHA. His research has been supported by the National Cancer Institute, USA, the Research Foundation Flanders, Belgium, and numerous Foundations, including the American Society of Hematology.
